Ireland’s EU drug-buying partnership secures first deal
The drug which the partnership agreed to fund is called Spinraza, which is used to treat Spinal Muscular Atrophy
The European partnership that aims to jointly negotiate pharmaceutical deals has reached its first collective pricing agreement.
The drug which the partnership agreed to fund is called Spinraza, which is used to treat Spinal Muscular Atrophy.
Spinraza is already being funded by the HSE in Ireland.
Subscribe from just 1€
Exclusive offers
Choose the subscription that is right for you
Monthly Subscription
€1
For the first month
€19.99 Monthly Thereafter
Subscribe todayCancel anytime
Annual Subscription
€200€149
For the first year
€199.99 annually thereafter
Subscribe todayCancel anytime
Quarterly Subscription
€55€42
For the first 90 days
€55.00 quarterly Thereafter
Subscribe todayCancel anytime
These offers are not available for current subscribers. Offers and pricing are subject to change without notice.
Terms & Conditions Apply
